These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

644 related articles for article (PubMed ID: 33621658)

  • 1. The ocular surface immune system through the eyes of aging.
    Galletti JG; de Paiva CS
    Ocul Surf; 2021 Apr; 20():139-162. PubMed ID: 33621658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A new approach for better comprehension of diseases of the ocular surface].
    Baudouin C
    J Fr Ophtalmol; 2007 Mar; 30(3):239-46. PubMed ID: 17417148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease.
    Farid M; Agrawal A; Fremgen D; Tao J; Chuyi H; Nesburn AB; BenMohamed L
    Ocul Immunol Inflamm; 2016 Jun; 24(3):327-47. PubMed ID: 25535823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin Eyedrops Increased CD4
    Trujillo-Vargas CM; Kutlehria S; Hernandez H; de Souza RG; Lee A; Yu Z; Pflugfelder SC; Singh M; de Paiva CS
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye.
    Guzmán M; Keitelman I; Sabbione F; Trevani AS; Giordano MN; Galletti JG
    Exp Eye Res; 2016 Oct; 151():19-22. PubMed ID: 27443502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease.
    Vijmasi T; Chen FY; Chen YT; Gallup M; McNamara N
    Mol Vis; 2013; 19():1957-65. PubMed ID: 24068863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of aging on the pathophysiology of dry eye disease: A systematic review and meta-analysis.
    Kitazawa K; Inomata T; Shih K; Hughes JB; Bozza N; Tomioka Y; Numa K; Yokoi N; Campisi J; Dana R; Sotozono C
    Ocul Surf; 2022 Jul; 25():108-118. PubMed ID: 35753664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry eye disease treatment: the role of tear substitutes, their future, and an updated classification.
    Barabino S; Benitez-Del-Castillo JM; Fuchsluger T; Labetoulle M; Malachkova N; Meloni M; Utheim TP; Rolando M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8642-8652. PubMed ID: 32964952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery of the conjunctiva.
    Yokoi N; Inatomi T; Kinoshita S
    Dev Ophthalmol; 2008; 41():138-158. PubMed ID: 18453766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ocular surface aging: Pathophysiology and consequences for management].
    Audelan T; Legrand M; M'Garrech M; Best AL; Barreau E; Labetoulle M; Rousseau A
    J Fr Ophtalmol; 2018 Mar; 41(3):262-270. PubMed ID: 29573862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular surface disease and dacryoadenitis in aging C57BL/6 mice.
    McClellan AJ; Volpe EA; Zhang X; Darlington GJ; Li DQ; Pflugfelder SC; de Paiva CS
    Am J Pathol; 2014 Mar; 184(3):631-43. PubMed ID: 24389165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
    Stern ME; Beuerman RW; Fox RI; Gao J; Mircheff AK; Pflugfelder SC
    Cornea; 1998 Nov; 17(6):584-9. PubMed ID: 9820935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ageing and ocular surface immunity.
    Mashaghi A; Hong J; Chauhan SK; Dana R
    Br J Ophthalmol; 2017 Jan; 101(1):1-5. PubMed ID: 27378485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Mucin and Glycoprotein Expression in Dry Eye Disease.
    Stephens DN; McNamara NA
    Optom Vis Sci; 2015 Sep; 92(9):931-8. PubMed ID: 26267059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why the eye becomes dry: a cornea and lacrimal gland feedback model.
    Mathers WD
    CLAO J; 2000 Jul; 26(3):159-65. PubMed ID: 10946988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Response in Dry Eye.
    Yamaguchi T
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES192-DES199. PubMed ID: 30481826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutical approach to dry eye syndrome].
    Babić GS; Zlatanović G; Jocić JD; Cekić S; Vujanović M
    Med Pregl; 2010; 63(11-12):793-800. PubMed ID: 21553457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preservation of tear film integrity and inhibition of corneal injury by dexamethasone in a rabbit model of lacrimal gland inflammation-induced dry eye.
    Nagelhout TJ; Gamache DA; Roberts L; Brady MT; Yanni JM
    J Ocul Pharmacol Ther; 2005 Apr; 21(2):139-48. PubMed ID: 15857280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes in ocular mucosal tolerance: Lessons learned from gut and respiratory tract immunity.
    Galletti JG; de Paiva CS
    Immunology; 2021 Sep; 164(1):43-56. PubMed ID: 33837534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune regulation of the ocular surface.
    Chen Y; Wang S; Alemi H; Dohlman T; Dana R
    Exp Eye Res; 2022 May; 218():109007. PubMed ID: 35257715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.